期刊文献+

miR-186通过下调垂体瘤转化基因1的表达抑制骨肉瘤细胞的增殖侵袭并诱导其凋亡 被引量:1

miR-186 suppresses the proliferation and invasion and promotes apoptosis of osteosarcoma cells partially through targeting PTTG1
原文传递
导出
摘要 目的:探讨miR-186对骨肉瘤细胞增殖、凋亡及侵袭能力的影响,并探讨其可能机制。方法:实时荧光定量PCR检测骨肉瘤细胞HOS、U2-OS、Saos-2及成骨细胞NHOst中miR-186表达,并运用人工合成的miR-186模拟片段及对照scramble mimic转染至人骨肉瘤HOS及U2-OS细胞内,运用实时荧光定量PCR检测转染后细胞中miR-186的表达水平;分别运用CCK-8法、流式细胞检测技术及Transwall体外侵袭实验检测过表达miR-186对HOS及U2-OS细胞增殖、凋亡及侵袭能力的影响;运用Western blotting及实时荧光定量PCR检测miR-186过表达对细胞中垂体瘤转化基因1(pituitary tumor transforming gene 1,PTTG1)的蛋白及m RNA表达水平的影响。结果:骨肉瘤细胞中miR-186呈现低表达;转染人工合成的miR-186片段可上调HOS及U2-OS细胞中miR-186的表达;miR-186过表达组细胞的增殖能力较scramble组明显下降(P<0.01),转染组HOS[(16.9±2.1)%vs(10.4±1.6)%,P<0.05]及U2-OS[(22.6±2.9)%vs(14.1±2.2)%,P<0.05]细胞的凋亡比例明显高于scramble组,转染组HOS及U2-OS细胞的穿膜数明显低于scramble组(P<0.01);转染组细胞中PTTG1的蛋白及m RNA表达水平均明显下降(P<0.01),而scramble组无明显变化(P>0.05);结论:miR-186能够抑制骨肉瘤细胞的增殖及侵袭并促进细胞凋亡,其作用机制可能与抑制PTTG1表达相关。 Objective: To explore the effects of miR-186 on the cell proliferation, apoptosis and invasion of human osteosarcoma cells, and identify its putative mechanisms. Methods: The expression of miR-186 in osteosarcoma cell lines(HOS, U2-OS and Saos-2) and osteoblast NHOst cells was detected using RT-PCR assays. Artificially synthesized miR-186 mimic and relative control scramble mimic was transfected into osteosarcoma HOS and U2-OS cell lines, and the expression of miR-186 in OS cells was detected using the RT-PCR assays upon transfection.Then, the effects of miR-186 over-expression on cell proliferation, apoptosis and invasion of OS cells were explored using the CCK-8, FCSE and transwell invasion assays, respectively. The effects of miR-186 over-expression on m RNA and protein expression of PTTG1(pituitary tumor transforming gene1) were explored using the Western blotting and RT-PCR assays. Results: miR-186 was low expressed in OS cell lines; Transfection with artificially synthesized miR-186 mimic significantly up-regulated the expression of miR-186 in HOS and U2-OS cells; the proliferation rate of cells transfected with miR-186 mimic was much lower than those transfected with scramble mimic[HOS:(16.9±2.1)% vs(10.4±1.6)%; U2-OS:(22.6±2.9)% vs(14.1±2.2)%;(P〈0.01); the apoptotic rates of HOS and U2-OS cells transfected with miR-186 mimic were higher than those transfected with scramble mimic [HOS:(16.9±2.1)% vs(10.4±1.6)%; U2-OS:(22.6±2.9)% vs(14.1±2.2)%; all P〈0.05], and the number of cells passing through the chambers in miR-186 mimic transfection group was less than those of scramble transfection group(P〈0.01).The expression levels of PTTG1 at protein and m RNA level were both suppressed in cells transfected with miR-186mimic(P〈0.01); however, scramble transfection group showed no statistical difference(P〈0.05). Conclusion: Overexpression of miR-186 significantly inhibited cell proliferation and invasion, and promoted the apoptosis of OS cells, which might be related with PTTG1 suppression.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2017年第8期864-869,共6页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.81502329) 重庆医科大学附属永川医院院内课题资助项目(No.YCZQN201514)~~
关键词 miR-186 骨肉瘤 垂体瘤转化基因1 miR-186 osteosarcoma pituitary tumor transforming gene 1(PTTG1)
  • 相关文献

参考文献1

二级参考文献16

  • 1Ragland BD,Bell WC,Lopez RR,et al.Cytogenetics and molecular biology of osteosarcoma[J].Lab Invest,2002,82 (4):365-373.
  • 2Jaffe N.Adjuvant chemotherapy in osteosarcoma:an odyssey of rejection and vindication[J].Cancer Treat Res,2009,152:219-237.
  • 3Zhang X,Horwitz GA,Prezant TR,et al.Structure,expression,and function of human pituitary tumor-transforming gene (PTTG)[J].Mol Endocrinol,1999,13(1):156-166.
  • 4Pei L,Melmed S.Isolation and characterization of a pituitary tumor-transforming gene (PTTG)[J].Mol Endocrinol,1997,11(4):433-441.
  • 5Hamid T,Kakar SS.PTTG and cancer[J].Histol Histopathol,2003,18 (1):245-251.
  • 6Yoon CH,Kim MJ,Lee H,et al.PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population[J].J Biol Chem,2012,287(23):19516-19527.
  • 7Salehi F,Scheithauer BW,Sharma S,et al.Immunohistochemical expression of PTTG in brain tumors[J].Anticancer Res,2013,33 (1):119-122.
  • 8Wondergem B,Zhang Z,Huang D,et al.Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma[J].Cancer Res,2012,72(17):4361-4371.
  • 9Feng ZZ,Chen JW,Yang ZR,et al.Expression of PTTG1 and PTEN in endometrial carcinoma:correlation with tumorigenesis and progression[J].Med Oncol,2012,29(1):304-310.
  • 10Ferguson-Smith AC,Reik W,Surani MA.Genomic imprinting and cancer[J].Cancer Surv,1990,9 (3):487-503.

共引文献5

同被引文献17

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部